2024-2025 Global AI Trends Guide
Ari Fridman
Counsel Global Regulatory
Ari defends clients being investigated by the US Congress. Drawing on his experience as a congressional investigator, he has prepared multiple executives to testify before the US Congress. Ari counsels clients on the prospect and reality of dealing with a congressional subpoena. He represents clients in a wide range of industries, including life science companies, universities, major insurance companies, and more.
Ari fully understands the congressional investigations process, taking written and unwritten rules and providing clients with practical advice for protecting their interests. He handles the entire process, from designing strategies to negotiating with Congressional committee staff to drafting responses to narrative interrogatories to running document reviews and productions. He has earned the trust of senior Congressional investigations staff members on Capitol Hill for his dependability and dedication to clients.
Ari is a registered lobbyist in multiple industries, including the live entertainment, insurance, telecommunications, and food industries. With a background in national security and foreign policy, he represents foreign governments before the US government. Ari advises clients on changing regulatory and statutory sanctions regimes against foreign governments, officials, and entities. Finally, Ari advises clients on their registration and reporting obligations under the Lobbying Disclosure Act (“LDA”) and the Foreign Agents Registration Act (“FARA”).
Advising a major Middle Eastern country as to its bilateral relationship with the United States, focusing on the U.S. Congress and U.S. Administration.
Advising a major Indo-Pacific country as to its bilateral to the United States, focusing on the U.S. Congress.
Advised a telecommunications company contemplating an engagement with a foreign government as to any obligations under the FARA.
Advised a Washington-based consulting firm with assessing both LDA and FARA compliance obligations.
Advised a US-based corporation formed to support democracy in a Middle Eastern country with assessing both LDA and FARA compliance obligations.
Representing a major university before the House Energy and Commerce Committee with respect to the campus’s handling of complaints of antisemitism from students and faculty.
Represented a major insurance company before a Senate Committee investigating the impact of climate change on the insurance industry.
Represented the ticketing arm of a major live entertainment company in an inquiry before a House Subcommittee, while preparing a senior executive to testify before the Subcommittee.
Represented a major public university in an inquiry before the Senate Permanent Subcommittee on Investigations with respect to the origins of the COVID-19 virus.
Represented a major research institution before the House Select Subcommittee on the Coronavirus Pandemic with respect to the origins of the COVID-19 virus.
Represented a preeminent trade association before the House Select Committee on the Chinese Communist Party with respect to U.S.-China trade policy.
Represented a major proxy advisory service provider before the House Judiciary Committee with respect to the alleged violation of antitrust laws regarding ESG-driven investment activity.
Represented an organ procurement organization (“OPO”) before the Senate Finance Committee with respect to inquiries over alleged conflicts of interest and record keeping practices.
Represented multiple OPOs before a House Subcommittee investigating alleged waste, fraud and abuse within the organ-donor community.
Represented a pharmaceutical company subject to a congressional inquiry concerning the marketing of opioid medications nationwide.
Represented a major healthcare company subject to a congressional inquiry concerning the pricing of multiple sclerosis therapies.
Represented a leading educational institution subject to a congressional inquiry concerning sexual harassment allegations against scientists and researchers within the scientific community.
Represented a major biopharmaceutical company in a prescription drug price congressional investigation.
Assisted in organizing the public policy, strategic communications, and media strategy for a foreign head of state's visit to the U.S.
Advised a major electronics company on compliance with U.S. sanctions and export control laws.